ImmunoCellular Therapeutics, Ltd. announced a private placement of convertible promissory notes for a gross proceeds of $5,000,000 in funding on August 26, 2022. The minimum investment accepted from any outside investor is $25,000. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1979 USD | 0.00% | 0.00% | -14.70% |
1st Jan change | Capi. | |
---|---|---|
-14.70% | 22.42M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- IMUC Stock
- News EOM Pharmaceuticals Holdings, Inc.
- EOM Pharmaceuticals Holdings, Inc. announced a financing transaction